Home » Topics » Conferences

Conferences
RSS

Antisense oligonucleotides for RSV infection

May 5, 1997

Roche describes TK inhibitors for recurrent HSV infection

May 5, 1997

Trimeris prepares potent peptide inhibitors of viral fusion

April 30, 1997

Potent inhibitors of HIV-1 and other enveloped viruses reported

April 30, 1997

Dendrimer polyanions with activity against RSV

April 30, 1997

Schering-Plough develops potent farnesyltransferase inhibitor

April 30, 1997

Vertex designs potent, conformationally restricted HIV protease inhibitors

April 30, 1997

Abbott discovers potent topical immunosuppressant with minimal systemic effects

April 30, 1997

Preclinical studies with GPI-2A reported by Genesys Pharma

April 30, 1997

Potent, selective and orally active COX-2 inhibitors from Parke-Davis

April 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...